Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02964741 · ClinicalTrials.gov registry record · NA
Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT02964741 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 44 participants.
The verdict
NCT02964741, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study investigates whether non-invasive brain stimulation, given for 20 minutes/once per day for ten days (M-F) can reduce migraine pain. Thirty patients will receive this treatment, while thirty will receive a "sham" procedure. Up to thirty healthy volunteers will be asked to undergo baseline assessments only (imaging, but no brain stimulation). Healthy volunteer data may be used from a prior study (NINDS-K23062946 project \[IRBMED #HUM00027383; Dr. Alexandre DaSilva, Principal Investigator\]).
Interventions
- DEVICE Sham Comparator
- DEVICE Active Comparator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2017-02-22 |
| Est. Completion | 2021-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02964741
The ClinicalTrials.gov registry entry for NCT02964741 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Comparator is the first listed.
NCT02964741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02964741 about?
NCT02964741 is a clinical study titled "Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)". This study investigates whether non-invasive brain stimulation, given for 20 minutes/once per day for ten days (M-F) can reduce migraine pain. Thirty patients will receive this treatment, while thirty will receive a "sham" procedure. Up to thirty healthy volunteers will be asked to undergo baseline ...
What is the current status of trial NCT02964741?
This trial is currently terminated. It is a NA study. The enrollment target is 44 participants. The study started on 2017-02-22. Estimated completion is 2021-08-01.
What interventions are being tested in trial NCT02964741?
The interventions under investigation include: Sham Comparator (DEVICE), Active Comparator (DEVICE).
Who is sponsoring clinical trial NCT02964741?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.